The CDC issued the warning Sept. 6, the same day health officials in California, Indiana and Minnesota each confirmed the death of a patient hospitalized with a vaping-related lung illness.
Nationwide, five deaths have been linked to the lung illnesses. The agency is investigating 450 confirmed and suspected cases in 33 states. In many of these cases, patients said they used vaping products containing marijuana prior to their hospitalization.
The CDC and FDA are working with state health officials to identify the cause of the illnesses. Officials identified a common chemical — vitamin E acetate — in samples of patients’ vaping products. However, the CDC says it’s still too early to confirm this chemical as the definitive source of the illnesses.
Editor’s note: This article was updated Sept. 9 at 8:20 a.m. to include an updated death count.
More articles on clinical leadership and infection control:
Eleanor Health opens 1st outpatient addiction clinic in North Carolina
How Cincinnati Children’s cut hospitalization rates 20% among high-risk youth
5 hospitals seeking CMOs
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.